Subcutaneous injections of platelet-rich plasma into skin flaps modulate proangiogenic gene expression and improve survival rates

Plastic and Reconstructive Surgery

Volumn 129, Issue 4, 2012, Pages 858-866

  Li, Weiwei ^a   Enomoto, Mitsuhiro ^a   Ukegawa, Madoka ^a   Hirai, Takashi ^a   Sotome, Shinichi ^a   Wakabayashi, Yoshiaki ^a   Shinomiya, Kenichi ^a   Okawa, Atsushi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB; SIGNAL PEPTIDE; TRANSFORMING GROWTH FACTOR BETA1; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL; ARTICLE; CHEMISTRY; GEL; GENE EXPRESSION; GENETICS; GRAFT SURVIVAL; MALE; METABOLISM; MICROVASCULATURE; NECROSIS; PATHOLOGY; PLASTIC SURGERY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE RICH PLASMA; VASCULARIZATION; WISTAR RAT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; GELS; GENE EXPRESSION; GRAFT SURVIVAL; INJECTIONS, SUBCUTANEOUS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICROVESSELS; NECROSIS; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-RICH PLASMA; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RATS, WISTAR; SURGICAL FLAPS; TRANSFORMING GROWTH FACTOR BETA1; VON WILLEBRAND FACTOR;

EID: 84859316966     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182450ac9     Document Type: Article

References (33)

1. Campbell SP, Moss ML, Hugo NE. When does a random flap die? Plast Reconstr Surg. 1992;89:718-721.
2. Andrews K, Mowlavi A, Neumeister MW, Russell RC. Ischemia- reperfusion injury: A multicellular phenomenon. Plast Reconstr Surg. 2000;106:1664-1665.
3. Demirseren ME, Sarici M, Gokrem S, Yenidunya S. Protective effects of monoclonal antibody to intercellular adhesion molecule-1 in venous ischemia-reperfusion injury: Experimental study in rats. J Reconstr Microsurg. 2007;23:41-44.
4. Engel H, Sauerbier M, Germann G, Küntscher MV. Dose dependent effects of nitric oxide donor in a rat flap model. Ann Plast Surg. 2007;58:456-460.
5. Kim EK, Hong JP. The effect of recombinant human erythropoietin on ischemia-reperfusion injury: An experimental study in a rat TRAM flap model. Plast Reconstr Surg. 2007; 120:1774-1781.
6. Zheng Y, Yi C, Xia W, et al. Mesenchymal stem cells transduced by vascular endothelial growth factor gene for ischemic random skin flaps. Plast Reconstr Surg. 2008;121:59-69.
7. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-676.
8. Zacchigna S, Papa G, Antonini A, et al. Improved survival ofischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adenoassociated virus vectors. Am J Pathol. 2005;167:981-991.
9. Kuo YR, Wang FS, Jeng SF, Lutz BS, Huang HC, Yang KD. Nitrosoglutathione improves blood perfusion and flap survival by suppressing iNOS but protecting eNOS expression in the flap vessels after ischemia/reperfusion injury. Surgery 2004;135:437-446.
10. Schmidmaier G, Herrmann S, Green J, et al. Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. Bone 2006;39:1156-1163.
11. Fréchette JP, Martineau I, Gagnon G. Platelet-rich plasmas: Growth factor content and roles in wound healing. J Dent Res. 2005;84:434-439.
12. Marx RE. Platelet-rich plasma: Evidence to support its use. J Oral Maxillofac Surg. 2004;62:489-496.
13. Dugrillon A, Klüter H. Current use of platelet concentrates for topical application in tissue repair. Ther Transfus Med. 2002;29:67-70.
14. Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofac Surg. 2000;58:297- 300; discussion 300-301.
15. Babbush CA, Kevy SV, Jacobson MS. An in vitro and in vivo evaluation of autologous platelet concentrate in oral econstruction. Implant Dent. 2003;12:24-34.
16. Anitua E, Sánchez M, Nurden AT, Nurden P, Orive G, Anda I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006;24:227-234.
17. Dugrillon A, Eichler H, Kern S, Klüter H. Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg. 2002;31:615-619.
18. Qi Z, Gu Y, Kim D, Hiura A, Sumi S, Inoue K. The effect of fibrin on the survival of ischemic skin flaps in rats. Plast Reconstr Surg. 2007;120:1148-1155.
19. Zhang Q, Chang Q, Cox RA, Gong X, Gould LJ. Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol. 2008;128:2102-2112.
20. Pfaffl MW. Relative quantification. In: Dorak MT, ed. Real- Time PCR. 1st ed. New York: Taylor & Francis; 2006.
21. DeRossi R, Coelho AC, Mello GS, et al. Effects of platelet-rich plasma gel on skin healing in surgical wound in horses. Acta Cir Bras. 2009;24:276-281.
22. Choi BH, Zhu SJ, Kim BY, Huh JY, Lee SH, Jung JH. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: An in vitro study. Int J Oral Maxillofac Surg. 2005;34:420-424.
23. Carter CA, Jolly DG, Worden CE Sr, Hendren DG, Kane CJ. Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol. 2003; 74:244-255.
24. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets: dentification of a major storage site, purification, and characterization. J Biol Chem. 1983;258:7155-7160.
25. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: Implications for wound healing. Plast Reconstr Surg. 2004; 114:1502-1508.
26. Folkman J, Browder T, Palmblad J. Angiogenesis research: Guidelines for translation to clinical application. Thromb Haemost. 2001;86:23-33.
27. Kliche S, Waltenberger J. VEGF receptor signaling and endothelial function. IUBMB Life 2001;52:61-66.
28. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis. Nature 1992;359:843-845.
29. Dai J, Rabie AB. VEGF: An essential mediator of both angiogenesis and endochondral ossification. J Dent Res. 2007;86:937-950.
30. Hosgood G. Wound healing: The role of platelet-derived growth factor and transforming growth factor beta. Vet Surg. 1993;22:490-495.
31. Resink TJ, Scott-Burden T, Hahn AW, et al. Specific growth stimulation of cultured smooth muscle cells from spontaneously hypertensive rats by platelet-derived growth factor Achain homodimer. Cell Regul. 1990;1:821-831.
32. Adelmann-Grill BC, Wach F, Cully Z, Hein R, Kreig T. Chemotactic migration of normal dermal fibroblasts towards epidermal growth factor and its modulation by platelet-derived growth factor and transforming growth factor-beta. Eur J Cell Biol. 1990;51:322-326.
33. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic- Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16:585-601.